about
Current perspectives on the immunopathogenesis of systemic sclerosisGenetics of systemic sclerosis: recent advancesGenetics, Epigenetics, and Genomics of Systemic SclerosisRecent advances in the genetics of systemic sclerosis: toward biological and clinical significanceAnalysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3Genetics of scleroderma: implications for personalized medicine?The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus.Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population.Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosisPathogenesis of Systemic Sclerosis.Involvement of collagen-binding heat shock protein 47 in scleroderma-associated fibrosis.A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosisKCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factorA systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility lociRole of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.New insight on the Xq28 association with systemic sclerosis.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesImmunochip analysis identifies multiple susceptibility loci for systemic sclerosis.Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility.Targeted therapies for systemic sclerosis.Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.Genetic risk factors for sclerotic graft-versus-host disease.Parental influence on systemic sclerosis.[Systemic scleroderma].No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway.The IL-33 gene is related to increased susceptibility to systemic sclerosis.TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling
P2860
Q26741264-3EC770E7-2BDF-4D3B-999A-09B5F4320320Q26796362-5A77E4C2-FECB-40F7-896A-CF75D7B423E7Q26799577-0094A8AF-C4B5-435B-9704-64A7BB2B535BQ28088499-329AE2D0-A3FF-44C0-AB89-D7CF352F6472Q34283946-E3FF9267-EC69-424F-85EE-01400B631A20Q34503686-B69DFC9A-1DFF-489F-9EA0-98A929B34151Q34545752-17EA048A-0C2D-4C45-ACE3-0DB902335A04Q34571170-2DCDC594-FBCF-44BC-BEC4-1A7CDC23BA5AQ34577218-01E8E746-83F7-463D-86D4-652118558CA7Q34623953-7AC08C95-AEFE-460A-8D36-3B13024FACA3Q34687497-CB5CF1E3-FFC1-47DE-A906-1CDBDEB1CCFEQ35623780-FB560637-E69C-413E-9311-82DFF02975C3Q35693212-E51A96CE-6AED-476B-9146-6E16C5943E94Q35862865-ED51ABCB-48C4-41F6-8434-BDAF684ECD07Q36245847-DC3783C0-2CFD-47E3-9192-C5B2EAABE227Q36907640-1B0CD2A1-10EC-4018-B457-B0FDB61BA90CQ37153818-2214253B-25CD-4EAC-9FE8-B0DB59CB4ADDQ37224668-D9EFD9B8-CCE4-4A4F-96D5-164D7EAB322CQ37282406-AF7475F4-BA01-4237-8042-E4F0E39A3B07Q37381549-9F20CCA1-7FBA-438C-ACA6-3034EB2278EBQ37441841-F13EF91B-4ADA-406A-A8DC-0A0B8B0672B1Q37460609-8F645429-E0A9-46A0-807A-FBF051212914Q37460616-F8FACEB3-DE44-411F-9780-EC139C9EB39AQ37690304-8A4BA0E7-F9CB-4E81-9E71-7F737E5FC3E7Q38097276-B290C33D-8728-41EB-AA79-6D7001DE5B1AQ40656308-4EDBD04C-B1BF-40C3-8C97-E9D95D61F3A5Q41108286-40FA8F18-A819-48EC-9AE3-3549605EAD7CQ45197707-44447689-03CB-4376-9DD3-A5F1F6A5D0F1Q45203681-B62FFEAD-F19F-452E-A376-28EC148BA03DQ47443055-E7E77CC9-210A-4B05-B889-86E4A7275F4CQ52862671-47D8FC24-D818-48B0-A144-E7F87A0B545FQ53220161-6B09D309-4DF8-4C5E-BD1A-6112B1A42050Q58585474-9B4CE67D-B7D1-4574-A8D1-74E8EA334F09
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Unraveling the genetic component of systemic sclerosis.
@en
Unraveling the genetic component of systemic sclerosis.
@nl
type
label
Unraveling the genetic component of systemic sclerosis.
@en
Unraveling the genetic component of systemic sclerosis.
@nl
prefLabel
Unraveling the genetic component of systemic sclerosis.
@en
Unraveling the genetic component of systemic sclerosis.
@nl
P2860
P50
P1433
P1476
Unraveling the genetic component of systemic sclerosis.
@en
P2860
P2888
P304
P356
10.1007/S00439-011-1137-Z
P577
2012-01-05T00:00:00Z